Sherif Badawy, MD from Ann & Robert H. Lurie Children’s Hospital of Chicago speaks about A systematic review of quality…
Browsing: Sickle Cell
Andrés Cervantes, MD from Pivotal discusses Highlight Therapeutics & Pivotal advance into a Phase IIa trial to examine Gastro-Intestinal cancer…
Francesca Vinchi, Ph.D. from the New York Blood Center speaks about “Breaking up†in Sickle Cell Anemia: Impacting Disease Pathophysiology…
Susanna Curtis, MD of Yale School of Medicine and Yale Cancer Center speaks about the Study: Medical Marijuana Associated with…
First Lady Melania Trump chairs a White House roundtable discussing sickle cell anemia.Â
Rafella Colombatti of University of Padova discusses the European perspective on sickle cell research.
Ifeyinwa (Ify) Osunkwo, MD of @LevineCancer explains the SWAY study on sickle cell disease.
Ifeyinwa (Ify) Osunkwo, MD of @LevineCancer discusses the unmet needs in sickle cell research.
Ifeyinwa (Ify) Osunkwo, MD of @LevineCancer discusses the unmet needs in sickle cell research.
Great strides have been made in the management of sickle cell disease. Here, Maria Cappellini, of the University of Milan-Foundation…
Speaking from the 23rd congress of the European Hematology Association (EHA) 2018 press briefing, held in Stockholm, Sweden, Dr Francesca…
There are three times more patients with sickle cell disease (SCD) than cystic fibrosis (CF) in the USA, yet SCD…
Speaking from the British Society for Haematology (BSH) 2018 Annual Scientific Meeting, in Liverpool, UK, Bart Biemond, MD, PhD, from…
In this interview, Bart Biemond, MD, PhD, from the Academic Medical Centre, Amsterdam, Netherlands, provides an insight is provided into…
Willem Ouwehand, MD, PhD, of the University of Cambridge, Cambridge, UK updates us on developments in clinical hematology at the…
Diversity in blood donors is crucial; there is a deficit in ethnic minority donors, which has a severe impact on…
Sickle cell disease (SCD) is a group of inherited blood disorders that result in a variety of acute illnesses, ultimately…
Minh-Ha Tran, DO, Associate Medical Director, Transfusion Medicine, Pathology School of Medicine discusses Adhesion molecules and the role of Rivipansel…
Yogenthiran Saunthararajah, MD of Cleveland Clinic discusses potential and non-toxic treatments for Sickle Cell Disease at the 58th ASH Annual…
Yogenthiran Saunthararajah, MD of Cleveland Clinic, discusses the current updates and trends surrounding treatment in Sickle Cell Disease at the…
Yogenthiran Saunthararajah, MD of Cleveland Clinic gives an overview of his abstract, Phase 1 Evaluation of Oral Tetrahydrouridine-Decitabine As Non-Cytotoxic…
Finbarr Cotter, MD, PhD from British Society of Hematology (BSH) Conferences and Barts Health NHS Trust, UK discusses some of…